Novartis and Emirates Oncology Society enter a partnership to spread awareness

Dubai: The pharmaceutical firm Novartis and Emirates Oncology Society have entered a partnership for 'United for Breast Cancer – A Commitment for Excellence and Innovation’.

Patients often lack a good understanding of their risk factors which can lead to delayed diagnosis and treatment. Complex and rapidly evolving treatment models can also lead to complicated decision-making patterns and a need for more local data generation.

“We are committed to transforming the standard of care for breast cancer patients and this is one area where significant advancements are possible,” said Mohamed Ezz Eldin, Head of Gulf Countries at Novartis. “Through this partnership, we aim to not only provide innovative treatment solutions but also foster a deeper understanding of the disease's complexities in the Gulf region.”